Rights and permissions
About this article
Cite this article
Biweekly paclitaxel plus gemcitabine highly active in advanced breast cancer. Inpharma Wkly. 1427, 14 (2004). https://doi.org/10.2165/00128413-200414270-00033
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414270-00033